blog navigation

blog posts

  • Study: Economic benefits of medical innovation undervalued

    Health care policymakers concerned about improving the management of health risks should view the pace of medical innovation as an important "lever of influence," says Julian Reif, a professor of finance and of economics at Illinois.

    Health care policymakers concerned about improving the management of health risks should view the pace of medical innovation as an important "lever of influence," says Julian Reif, a professor of finance and of economics at Illinois.

    Photo by L. Brian Stauffer

    Images

blog posts

  • Editor’s note: To contact Julian Reif, email jreif@illinois.edu. The paper, “The Insurance Value of Medical Innovation,” is available online.